World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
27966
World Ranking
17420
National Ranking
656

Cyriel Y. Ponsioen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Cyriel Y. Ponsioen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 370 publications — 32nd percentile

32% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Cyriel Y. Ponsioen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Cyriel Y. Ponsioen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Cyriel Y. Ponsioen is affiliated with the University of Amsterdam in the Netherlands. Their research primarily spans the field of medicine, contributing extensively within several subfields such as surgery, epidemiology, hepatology, pulmonary and respiratory medicine, and genetics.

Their academic output includes a range of topics focused on liver diseases and immunity, gallbladder and bile duct disorders, and inflammatory bowel disease. They have also engaged in research related to liver disease diagnosis and treatment, pediatric hepatobiliary diseases and treatments, cholangiocarcinoma and gallbladder cancer studies, as well as microscopic colitis.

Frequent coauthors throughout their career include:

  • Geert D'Haens
  • Marjolijn Duijvestein
  • Bettina E. Hansen
  • K Gecse
  • Ulrich Beuers

Their work has been published repeatedly in several scientific venues. Among the most frequent are:

  • Journal of Hepatology
  • Journal of Crohn's and Colitis
  • Gastroenterology
  • Gastrointestinal Endoscopy
  • Liver International

Recent publications by Cyriel Y. Ponsioen include:

  • "Drivers and determinants of strain dynamics following fecal microbiota transplantation," 2022, Nature Medicine
  • "Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial," 2020, The Lancet. Gastroenterology & Hepatology
  • "Large-scale sequencing identifies multiple genes and rare variants associated with Crohn's disease susceptibility," 2022, Nature Genetics
  • "Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase," 2020, The American Journal of Gastroenterology
  • "A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group," 2020, United European Gastroenterology Journal

Best Publications

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr

  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

    Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke

  • Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis

    Noortje G. Rossen;Susana Fuentes;Mirjam J. van der Spek;Jan G. Tijssen

  • Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review

    Kirsten Boonstra;Ulrich Beuers;Cyriel Y. Ponsioen

  • Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis.

    Kirsten Boonstra;Rinse K. Weersma;Karel J. van Erpecum;Erik A. Rauws

  • Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: An international follow-up study

    Willem J. Lammers;Henk R. van Buuren;Gideon M. Hirschfield;Harry L.A. Janssen

  • Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study

    Mirthe Emilie van der Valk;Marie-Josée J Mangen;Max Leenders;Gerard Dijkstra

  • Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis

    Tobias J. Weismüller;Tobias J. Weismüller;Palak J. Trivedi;Annika Bergquist;Mohamad Imam;Mohamad Imam

  • Loss of Infliximab Into Feces Is Associated With Lack of Response to Therapy in Patients With Severe Ulcerative Colitis

    Johannan F. Brandse;Gijs R. van den Brink;Manon E. Wildenberg;Desiree van der Kleij

  • Development and Validation of a Scoring System to Predict Outcomes of Patients With Primary Biliary Cirrhosis Receiving Ursodeoxycholic Acid Therapy

    Willem J. Lammers;Gideon M. Hirschfield;Christophe Corpechot;Frederik Nevens

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z Liu;Johannes Roksund Hov;Trine Folseraas;Trine Folseraas;Eva Ellinghaus

  • Genome-Wide Association Analysis in Primary Sclerosing Cholangitis

    Tom H. Karlsen;Andre Franke;Espen Melum;Arthur Kaser

  • Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population

    C Y Ponsioen;S M E Vrouenraets;W Prawirodirdjo;R Rajaram

  • Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: a randomised controlled, open-label, multicentre trial

    Cyriel Y Ponsioen;E Joline de Groof;Emma J Eshuis;Tjibbe J Gardenbroek

  • Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci

    Espen Melum;Andre Franke;Christoph Schramm;Tobias J Weismüller

  • Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

    Noortje G Rossen;John K MacDonald;Elisabeth M de Vries;Geert R D'Haens

  • Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline.

    Lars Aabakken;Tomh. Karlsen;Joerg Albert;Marianna Arvanitakis

  • Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci

    Trine Folseraas;Trine Folseraas;Espen Melum;Espen Melum;Philipp Rausch;Brian D. Juran

  • European Society of Gastrointestinal Endoscopy, European Society of Gastroenterology and Endoscopy Nurses and Associates, and the European Society of Anaesthesiology Guideline: Non-anesthesiologist administration of propofol for GI endoscopy

    Jean-Marc Dumonceau;A. Riphaus;J. R. Aparicio;U. Beilenhoff

  • Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis

    Jimmy Z. Liu;Johannes Roksund Hov;Trine Folseraas;Eva Ellinghaus

Frequent Co-Authors

Geert R. D'Haens
Geert R. D'Haens University of Amsterdam
Gideon M. Hirschfield
Gideon M. Hirschfield University Health Network
Albert Parés
Albert Parés University of Barcelona
Rinse K. Weersma
Rinse K. Weersma University Medical Center Groningen
Bettina E. Hansen
Bettina E. Hansen University Health Network
Keith D. Lindor
Keith D. Lindor Arizona State University
Ulrich Beuers
Ulrich Beuers University of Amsterdam
Tom H. Karlsen
Tom H. Karlsen Oslo University Hospital
Kirsten Muri Boberg
Kirsten Muri Boberg University of Oslo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA is a popular choice, there are several related online degrees and career pathways that provide rewarding opportunities in healthcare. For example, if you are interested in nursing, you may wonder, do you have to take the teas test to get into nursing school? Some programs offer options that may not require these entrance exams.

For those seeking roles in healthcare management, pursuing an online healthcare management degree can open doors to leadership positions in hospitals or clinics. Registered nurses hoping to advance can benefit from adn to msn bridge programs, which help fast-track educational and career growth.

Nutrition also plays a vital role in patient health. Earning an online bachelor's in nutrition can lead to impactful careers promoting wellness and disease prevention.

With these flexible online options, aspiring healthcare professionals can tailor their education to fit their goals and schedules while expanding their career horizons.

Best Scientists Citing Cyriel Y. Ponsioen

Trending Scientists

Recently Published Articles